Research programme: VEGF inhibitors - Interprotein
Latest Information Update: 08 Dec 2013
At a glance
- Originator Interprotein Corporation
- Class Antibodies; Peptides; Small molecules
- Mechanism of Action Vascular endothelial growth factor A inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 26 Nov 2013 Early research is ongoing in Japan
- 21 Nov 2008 Early research in Solid tumours in Japan (PO)